Cargando…
Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome
Metabolic syndrome (MetS) is a cluster of risk factors that lead to microvascular dysfunction and chronic cerebral hypoperfusion (CCH). Long-standing reduction in oxygen and energy supply leads to brain hypoxia and protein misfolding, thereby linking CCH to Alzheimer's disease. Protein misfoldi...
Autores principales: | Herrera, María I., Udovin, Lucas D., Toro-Urrego, Nicolás, Kusnier, Carlos F., Luaces, Juan P., Otero-Losada, Matilde, Capani, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990610/ https://www.ncbi.nlm.nih.gov/pubmed/29904335 http://dx.doi.org/10.3389/fnins.2018.00339 |
Ejemplares similares
-
Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A translational perspective
por: Bordet, Sofía, et al.
Publicado: (2023) -
Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain
por: Herrera, María I., et al.
Publicado: (2018) -
Palmitoylethanolamide attenuates neurodevelopmental delay and early hippocampal damage following perinatal asphyxia in rats
por: Herrera, Maria I., et al.
Publicado: (2022) -
Corrigendum: Palmitoylethanolamide attenuates neurodevelopmental delay and early hippocampal damage following perinatal asphyxia in rats
por: Herrera, Maria I., et al.
Publicado: (2022) -
Partial Reversal of Striatal Damage by Palmitoylethanolamide Administration Following Perinatal Asphyxia
por: Udovin, Lucas D., et al.
Publicado: (2020)